877 Jefferson Avenue, Memphis, TN, 38103 · (901) 545-7928
Beds
291
FY 2025
Star rating
1 of 5
Patient survey: 2 of 5
Net patient revenue
$453.3M
FY 2025
Net income
-$5.0M
Patient care margin -78.3%
Discharges
13,913
Occupancy 81.9%
Clinicians
403
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $453.3M | $808.1M | -78.3% | -$5.0M | 13,913 | $70.1M | 6.9% | 1.6% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Hospital-wide death rate within 30 days | 4.5% | US median 3.9% |
| Readmission rate for COPD | 19.8% | US median 19.8% |
| Readmission rate for heart failure | 20.7% | US median 21.3% |
| Readmission rate for pneumonia | 17% | US median 17.2% |
| Serious complications (patient safety composite) | 1.20 | US median 0.96 |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $440.4M | $758.6M | -72.3% | -$1.2M | 13,913 | $64.4M | 6.8% | 2.6% |
| 2023 | $407.9M | $730.1M | -79.0% | -$3.6M | 13,913 | $69.1M | 7.3% | 1.3% |
| 2022 | $556.2M | $653.2M | -17.4% | -$6.4M | 13,144 | $69.7M | 8.9% | 1.6% |
| 2021 | $414.4M | $593.0M | -43.1% | -$3.5M | 10,124 | $57.4M | 9.3% | 1.7% |
| 2020 | $366.7M | $513.9M | -40.2% | -$15.3M | 9,046 | $60.7M | 9.0% | 1.6% |
| C. diff intestinal infections (ratio to expected) | 0.22 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.56 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.27 | US median 0.72 · better |
| MRSA bloodstream infections (ratio to expected) | 4.77 | US median 0.60 · worse |
| Catheter urinary tract infections (ratio to expected) | 0.25 | US median 0.40 · better |
| Doctors always communicated well | 75% | US median 79% |
| Nurses always communicated well | 70% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 54% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 61% | US median 72% |
| Room and bathroom always clean | 63% | US median 73% |
| Patients who would definitely recommend the hospital | 67% | US median 71% |
| Patients who left the emergency department before being seen | 3% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 294 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 9% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 34% | US median 65% |
| Healthcare workers given the flu vaccine | 99% | US median 79% |
| 28 |
| $103,627.14 |
| $25,862.18 |
| $15,801.33 |
| DRG 552 MEDICAL BACK PROBLEMS WITHOUT MCC | 25 | $54,393.24 | $15,791.44 | $7,114.44 |
| DRG 085 TRAUMATIC STUPOR AND COMA <1 HOUR WITH MCC | 21 | $97,530.57 | $26,842.38 | $18,598.74 |
| DRG 551 MEDICAL BACK PROBLEMS WITH MCC | 20 | $61,441.55 | $22,161.60 | $13,310.40 |
| DRG 964 OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC | 18 | $70,966.89 | $19,338.61 | $13,599.22 |
| DRG 493 LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH CC | 17 | $123,721.35 | $28,695.12 | $18,731.31 |
| DRG 183 MAJOR CHEST TRAUMA WITH MCC | 15 | $74,730.67 | $20,590.87 | $13,356.99 |
| DRG 812 RED BLOOD CELL DISORDERS WITHOUT MCC | 14 | $30,570.71 | $16,787.00 | $7,177.67 |
| DRG 956 LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA | 13 | $193,680.92 | $37,272.77 | $32,828.06 |
| DRG 184 MAJOR CHEST TRAUMA WITH CC | 13 | $60,717.46 | $16,643.00 | $8,198.25 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 13 | $190,098.92 | $48,695.08 | $40,556.82 |
| DRG 958 OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC | 12 | $156,843.08 | $42,002.25 | $39,297.74 |
| DRG 522 HIP REPLACEMENT WITH PRINCIPAL DIAGNOSIS OF HIP FRACTURE WITHOUT MCC | 12 | $92,630.17 | $26,064.83 | $15,768.13 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5372 Level 2 Urology and Related Services | 90 | 57 | $453.61 | $502.15 |
| APC 8011 Comprehensive Observation Services | 74 | 69 | $1,766.91 | $2,090.36 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 69 | 28 | $892.67 | $2,141.49 |
| APC 5373 Level 3 Urology and Related Services | 67 | 59 | $1,330.19 | $1,516.28 |
| APC 5463 Level 3 Neurostimulator and Related Procedures | 40 | 40 | $9,617.77 | $11,549.97 |
| APC 5183 Level 3 Vascular Procedures | 31 | 26 | $2,054.92 | $2,405.01 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 30 | 30 | $1,025.40 | $1,219.56 |
| APC 5374 Level 4 Urology and Related Services | 26 | 21 | $2,312.68 | $2,629.24 |
| APC 5114 Level 4 Musculoskeletal Procedures | 16 | 13 | $3,869.62 | $5,338.75 |
| APC 5375 Level 5 Urology and Related Services | 12 | 11 | $3,455.32 | $3,917.51 |
| APC 5115 Level 5 Musculoskeletal Procedures | 11 | 11 | $9,357.15 | $10,771.69 |
| APC 5163 Level 3 ENT Procedures | - | - | - | $1,105.91 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Central Admixture Pharmacy Services, Inc. | 1 | $43K |
| Stryker Corporation SYK | 6 | $40K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $22K |
| Avita Medical Americas, LLC | 1 | $20K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $5,000 |
| Masimo Corporation MASI | 7 | $4,015 |
| CSL Behring CSL.AX | 1 | $3,000 |
| Aesculap, Inc. | 1 | $1,362 |
| Medline Industries LP | 2 | $1,096 |
| Abbott Laboratories ABT | 5 | $766 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Regional One Health is a nonprofit short-term acute care hospital in Memphis, TN with 291 beds, part of Regional One Health and a 1-star overall rating.
Regional One Health in Memphis, TN has 291 beds (fiscal year 2025 cost report); 631 beds are certified for Medicare. It discharged 13,913 inpatients that year, with 81.9% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Regional One Health reported net patient revenue of $453.3M and operating expenses of $808.1M, a margin on patient care of -78.3%. After other income and expenses its net income was -$5.0M (-0.6% of revenue), so it lost money that year.
Regional One Health is part of Regional One Health, a health system with 2 hospitals based in Memphis, TN. It is a nonprofit hospital.
Regional One Health has an overall rating of 1 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey.
Yes, Regional One Health provides emergency services.
403 Medicare clinicians list Regional One Health as a hospital they work at, most often in Nurse Practitioner, Certified Registered Nurse Anesthetist (Crna), Anesthesiology.
In 2024, Regional One Health had 329 Medicare inpatient stays in 18 diagnosis groups. The most common was DRG 086 (traumatic stupor and coma <1 hour with cc) with 40 stays; Medicare paid $18,184.33 per stay on average, compared with $10,198.29 across all hospitals.
In 2025, companies reported $140K in payments to Regional One Health as a teaching hospital ($59K general and $80K for research) from 12 companies.